Use of flavolignans as adjuvants in tumour therapy

Details Use of flavolignans as adjuvants in tumour therapy Use of flavolignans as adjuvants in tumour therapy

1995-01-24

1998-02-03

Mullis, Jeffrey C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Lignin or derivative doai

514574, A61K 3119, A61K 3136

Patent

active

057144737

ABSTRACT:
The present invention is concerned with the use of flavolignans as adjuvants in the case of chemotherapeutic tumour treatment and for the protection of cells in the urogenital region.

REFERENCES:
patent: 4871763 (1989-10-01), Madaus et al.
Abraham et al., "The Structure of Silydianin, an Isomer of Silymarin (Silybin)", by X-ray Analysis, Tetrahedron LTRS. No. 31, pp. 2675-2678, 1970.
Pelter et al., "The Structure of Silybin (Silybum Substance E6)", The First Flavonolignan, Tetrahedron LTRS. No. 25, pp. 2911-2916, 1968.
H. Wagner et al., "The Structure of Silychristin", A Second Silymarin Isomer From Silybum Marianum Tetrahedron LTRS. No. 22, pp. 1895-1899, 1971.
Physicians' Desk Reference, 48.sup.th Edition 1994 pp. 458-461, 666-669, Medical Economics Data Production Company, Montvale, N.J. (Dec. 1993).
CA 103:32031, Miyazaki et al. (1985).
CA 91:84686, Vogel et al. (1979).

Affiliated with

Also associated with

Rating

Use of flavolignans as adjuvants in tumour therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of flavolignans as adjuvants in tumour therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of flavolignans as adjuvants in tumour therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-662438